FDA Investigator Jessica S Estriplet
Jessica S Estriplet has inspections in 2 countries as of 13 Oct 2023. Jessica S Estriplet has collaborated with a combined 1369 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
16
Last Inspection Date:
13 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
Canada
Co-Investigator(s):
Alberto A Viciedo,
Alice S Tsao,
Allen Lou,
Amy L Singer,
Ankur C Patel,
Annet R Rajan,
Barbara J Maulfair,
Brandy N Lepage,
Brian S Keefer,
Cara M Minelli,
Charlotte E Wilkins,
Christina K Theodorou,
Craig D Zagata,
Daniel J Grabicki,
Daniel T Lee,
David J Hafner,
Denise M Digiulio,
Douglas C Kovacs,
Edward D Mcdonald,
Emmanuel J Ramos,
Eric Rothschild,
Esther C Broner, PhD,
Frederick Razzaghi,
Guerlain Ulysse,
Helen B Ricalde,
Helen Verdel,
James M Mason,
James Norman,
Jay B Shah,
Jazmine N Brown,
Jogy George,
John P Mistler,
Jose M Cayuela,
Josh Renzon Ramilo,
Juanita P Versace,
Junho Pak,
Karen A Briggs,
Karen E D'orazio,
Kelli F Dobilas,
Kristina J Donohue,
Lata C Mathew, PhD,
LCDR Susan E Polifko,
Li Li,
Liatte Kreuger, PharmD,
Lisa M Bellows,
Lisa Relloos,
Marcellinus D Dordunoo,
Marcia D Fields,
Mary R Kirker,
Michael A Taylor,
Michael R Klapal,
Nancy F Scheraga,
Nancy M Espinal,
Nicholas A Violand,
Niketa Patel,
Paul L Bellamy,
Peter R Lenahan,
Rachel C Harrington,
Regina T Brown,
Saleem A Akhtar,
Sena G Dissmeyer,
Simone E Pitts,
Stephen J Mottola,
Stephenie M Ortiz,
Susan F Laska, MS,
Tara G Bizjak,
Tarun D Mehta,
Thomas E Friel,
Tiffani D Wilson,
Tonia F Bernard,
Travis R Hunt,
Unnee Ranjan,
Valerie C Reed,
Vlada Matusovsky,
William J Leonard,
William J Muszynski,
Yoriann Mcabrera Bartolomei,
Yvesna C Blaise,
Yvins Dezan,
Zhong Li, PhD
Jessica S Estriplet's Documents
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more